BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7686301)

  • 1. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.
    Mantovani L; Wilder RL; Casali P
    J Immunol; 1993 Jul; 151(1):473-88. PubMed ID: 7686945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.
    Fornasieri A; Bernasconi P; Ribero ML; Sinico RA; Fasola M; Zhou J; Portera G; Tagger A; Gibelli A; D'amico G
    Clin Exp Immunol; 2000 Dec; 122(3):400-3. PubMed ID: 11122246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.
    Damle RN; Calissano C; Chiorazzi N
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):33-45. PubMed ID: 20620969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of allelic exclusion in B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1997 Apr; 185(8):1435-45. PubMed ID: 9126924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
    Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
    Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil.
    Mellstedt H; Choudhury A
    Cancer Immunol Immunother; 2006 Feb; 55(2):210-20. PubMed ID: 15906026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukaemia.
    Kipps TJ; Stevenson FK; Wu CJ; Croce CM; Packham G; Wierda WG; O'Brien S; Gribben J; Rai K
    Nat Rev Dis Primers; 2017 Jan; 3():16096. PubMed ID: 28102226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.
    Nguyen Van Long F; Valcourt-Gendron D; Caron P; Rouleau M; Villeneuve L; Simonyan D; Le T; Sergerie R; Laverdière I; Vanura K; Guillemette C
    Clin Transl Med; 2023 Dec; 13(12):e1442. PubMed ID: 38037464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and indolent chronic lymphocytic leukaemia--immune and hormonal peculiarities.
    Everaus H; Luik E; Lehtmaa J
    Cancer Immunol Immunother; 1997 Oct; 45(2):109-14. PubMed ID: 9390202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies.
    Khan S; Allsup D; Molica S
    Front Oncol; 2023; 13():1135812. PubMed ID: 37091176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-9 in CLL: sensing home and settling down!
    Ringshausen I
    Blood; 2021 Apr; 137(16):2130-2131. PubMed ID: 33885714
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia.
    Gharagozloo S; Khoshnoodi J; Shokri F
    Pathol Oncol Res; 2001; 7(2):135-9. PubMed ID: 11458277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expressed immunoglobulin variable region heavy chain gene products in paraproteins from Iranian patients with multiple myeloma.
    Gharagozloo S; Sharifian RA; Mageed RA; Shokri F
    Pathol Oncol Res; 2000; 6(3):185-90. PubMed ID: 11033458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia.
    Moazzeni SM; Amirzargar AA; Shokri F
    Pathol Oncol Res; 1999; 5(2):142-5. PubMed ID: 10393367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and survival of B-chronic lymphocytic leukaemia cells.
    Söderberg O
    Med Oncol; 1998 Jul; 15(2):73-8. PubMed ID: 9789213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number.
    Sasso EH; Johnson T; Kipps TJ
    J Clin Invest; 1996 May; 97(9):2074-80. PubMed ID: 8621797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased utilization of immunoglobulin variable region heavy- and light-chain genes by the malignant CD5- B lymphocytes from patients with Burkitt's lymphoma.
    Moazzeni M; Mosayyebi G; Stevenson FK; Abbot S; Mageed RA; Shokri F
    Int J Cancer; 1994 Jul; 58(2):226-32. PubMed ID: 7517918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies.
    Kipps TJ; Robbins BA; Tefferi A; Meisenholder G; Banks PM; Carson DA
    Am J Pathol; 1990 Apr; 136(4):809-16. PubMed ID: 1691593
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.